Diagnostics Channel Icon

Molecular technologies are essential to accurately understand and effectively diagnose disease and guide therapy. The Diagnostics Channel will bring together industry leaders to discuss best practices in the creation and implementation of tools to enable precision medicine.

Molecular Diagnostics

Personalized Diagnostics

Cancer Molecular Markers

Circulating Tumor Cells

Digital Pathology

Precision Medicine – New

PCR for Molecular Medicine

Clinical NGS Diagnostics

Genomic Sample Prep and Biomarker Assay Development

Molecular Diagnostics for Infectious Disease – New


Genomics Channel

As researchers continue to unveil the importance and role of the human genome in diagnosis and treatment of disease, it will be critical to maintain a multi-faceted approach. Covering everything from sample preparation to data interpretation and integration, the Genomics Channel will showcase the techniques, technologies, and emerging trends in precision medicine and beyond.

Precision Medicine - New

PCR for Molecular Medicine

Clinical NGS Diagnostics

Genomic Sample Prep and Biomarker Assay Development


Cancer-Channel Icon

The heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, genomic-based and immune-modulated therapies that are enabling precision oncology.

Cancer Molecular Markers

Circulating Tumor Cells

Cancer Immunotherapy - New

Predictive Preclinical Models in Oncology



The Informatics Channel gathers leading experts in big data science, drug discovery informatics, bioinformatics, and IT to explore cutting edge ways to manage, analyze, and integrate data that will transform our understanding of translational research and precision medicine.

Bioinformatics for Big Data

Integrated Informatics Driving TranslationalResearch & Precision Medicine


2016 MMTC Symposia

Join us March 10-11 at the Hilton San Francisco Union Square for one of The Tri-Conference’s “must attend” symposia. Chose to just attend the symposia portion of the Tri-Conference, or add it on to your “All-Access” Pass.

New Frontiers in Gene Editing

Circulating Cell-Free DNA

Point-of-Care Diagnostics

Biomarkers for Cancer Immunotherapy

Genomics & Sequencing Data Integration, Analysis and Visualization

Companion Diagnostics

Commercialization of Molecular Diagnostics – New


Premier Sponsors

NeoGenomics

Seegene